Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TianYu Bio-Technology CoSHSE:603717 +2.19%44 PS Ratio is 2.90 as of Aug. 18, 2026, which is 3% above its 10-year median of 2.82. GuruFocus rates SHSE:603717 with a GF Score™ of 44/100 and a GF Value™ of ¥5.71 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 1,771 Construction companies, TianYu Bio-Technology Co ranks worse than 82.38% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, TianYu Bio-Technology Co's share price is ¥6.52.
TianYu Bio-Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was ¥2.25. Hence, TianYu Bio-Technology Co's PS Ratio for today is 2.90.
The historical rank and industry rank for TianYu Bio-Technology Co's PS Ratio or its related term are showing as below:
SHSE:603717'
s PS Ratio Range Over the Past 10 Years
Min: 1.67 Med: 2.82 Max: 6.47
Current: 2.9
During the past 13 years, TianYu Bio-Technology Co's highest PS Ratio was 6.47. The lowest was 1.67. And the median was 2.82.
SHSE:603717's PS Ratio is ranked worse than 82.38% of 1771
companies
in the Construction industry
Industry Median: 0.88
vs SHSE:603717: 2.90
TianYu Bio-Technology Co Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of TianYu Bio-Technology Co was -20.00% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -8.40% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 0.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -6.70% per year.
During the past 13 years, TianYu Bio-Technology Co's highest 3-Year average Revenue per Share Growth Rate was 4.80% per year. The lowest was -31.80% per year. And the median was -2.00% per year.
TianYu Bio-Technology Co (SHSE:603717) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Engineering & Construction subindustry, TianYu Bio-Technology Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TianYu Bio-Technology Co PS Ratio vs Construction Industry
For the Construction industry and Industrials sector, TianYu Bio-Technology Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where TianYu Bio-Technology Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
TianYu Bio-Technology Co's Share Price of today is ¥6.52. TianYu Bio-Technology Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.25.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
TianYu Bio-Technology Co (SHSE:603717) has a PS Ratio of 2.90 as of Aug. 18, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on TianYu Bio-Technology Co and its competitors. This is near median its historical median of 2.82. Over the past decade, TianYu Bio-Technology Co's PS Ratio has ranged from 1.67 to 6.47. According to the industry distribution chart, TianYu Bio-Technology Co ranks #1459 out of 1771 companies in the Construction industry, placing it in the top 82.4%.
Is TianYu Bio-Technology Co's PS Ratio too high?
TianYu Bio-Technology Co's current PS Ratio of 2.90 is near median its 10-year median of 2.82. Over the past 10 years, this metric has ranged from a low of 1.67 to a high of 6.47. The Construction industry median PS Ratio is 0.88. TianYu Bio-Technology Co's value of 2.90 is 229.5% above this industry median. Based on the distribution chart, TianYu Bio-Technology Co ranks #1459 out of 1771 companies in the Construction industry, which is in the bottom quartile relative to peers. Overall, TianYu Bio-Technology Co has a GF Score™ of 44/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TianYu Bio-Technology Co's PS Ratio compare to PWR and FIX?
According to the Construction industry distribution chart, TianYu Bio-Technology Co ranks #1459 out of 1771 companies for PS Ratio. This places TianYu Bio-Technology Co in the lower half of its industry. The industry median PS Ratio is 0.88. TianYu Bio-Technology Co's value of 2.90 is 229.5% above this benchmark. Historically, TianYu Bio-Technology Co's own PS Ratio has ranged from 1.67 to 6.47 over the past decade. While the company's 10-year median is 2.82 vs. the industry median of 0.88, TianYu Bio-Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Construction company?
The median PS Ratio among Construction companies is 0.88, based on 1,771 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TianYu Bio-Technology Co's current PS Ratio of 2.90 is 229.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on TianYu Bio-Technology Co and its competitors. For the Construction industry, the median PS Ratio is 0.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TianYu Bio-Technology Co's current PS Ratio is 2.90, which is near median its own 10-year median of 2.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TianYu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, TianYu Bio-Technology Co (SHSE:603717) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥5.71, compared to a current price of ¥6.52 — trading 14.2% above its estimated fair value. The current PS Ratio is 2.90, which is near median its 10-year median of 2.82 and 229.5% above the Construction industry median of 0.88. TianYu Bio-Technology Co's overall GF Score™ is 44/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For TianYu Bio-Technology Co (SHSE:603717), the current PS Ratio is 2.90 as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TianYu Bio-Technology Co (SHSE:603717) Overvalued in 2026?
Based on GuruFocus' analysis, TianYu Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥6.52 is trading 14.2% above its estimated GF Value™ of ¥5.71.
GuruFocus considers TianYu Bio-Technology Co to be Modestly Overvalued.
Key valuation signals for SHSE:603717:
PS Ratio: 2.90 (near median its 10-year median of 2.82)
GF Value™: ¥5.71 vs. price of ¥6.52 (14.2% above fair value)
Industry Position: 229.5% above the Construction median (#1459 of 1771)
No single metric tells the full story. See the SHSE:603717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TianYu Bio-Technology Co Ltd is engaged in Garden ecological engineering business, ecological environment management and rural complex business, pig breeding business, production and marketing of agricultural products and cash crops.
44GF Score
Get the complete analysis for SHSE:603717
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603717 has been successfully added to your 
